DigitalHealth InvestorTalk Show

What are the changing priorities of the software budgets of the major healthcare sectors? The problems facing healthcare incumbents keep changing and so their budget strength and priorities also change. We take a look at the problems and budget strengths today for buying tech by Providers, Payers, Employers, and Pharma. In this show we'll cover: - Today's significant problems facing the different sectors of healthcare. - The strength of healthcare budgets and spendiness on tech. - Conclusions investors are drawing and where they're putting their chips. And we'll answer your questions. Adam Kaufman is the publisher of BearingOn.Health and an adjunct professor of economics at USC. Follow him at: https://www.linkedin.com/in/adkaufman/. Steven Wardell is the Managing Director of Wardell Advisors, a digital health business-development consulting firm, and the author of The Future of Digital Health.

Digital health sectors are maturing and consolidators are circling. Have some recent acquisitions kicked off the game of musical chairs? In the show we’ll dive into: - There has been tremendous entry of innovators into healthcare since 2009 but consolidation has typically been weak - Some recent acquisitions like Virgin Pulse & HealthComp and Veradigm's acquisition of ScienceIO show that the pace is picking up - We look at the different subsectors of digital health, the consolidators in each subsector, and the potential for big tech and other outsiders to pounce And we'll answer your questions Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633 Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

We've lived through an unprecedented period of new digital health products and companies. Consolidation follows. In the show we’ll dive into: - There has been tremendous entry of new products and companies into all the subsectors of digital health since 2009 but sector consolidation has been consistently weak - As the sector matures, we're seeing product buyers move toward the enterprise buy and suite-level functionality, driving new consolidation activity - Will we see a seller's market for digital health companies or a buyer's market And we'll answer your questions Ari Tulla is the Founder and CEO of Elo Health, an AI personalization engine delivering the exact nutrients to live better. And he is an investor in byFounders Collective, an early-stage venture fund. You can follow him on X.com/Umbar. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Why we need a new city for our biggest innovations, what a health innovation city should include, and how it's going in Vitalia In the show we’ll dive into: - What it takes to build a new health innovation city and how this new foundation will enable fast clinical trials, patient right-to-try, and much more - What's going on at Vitalia City (vitalia.city) and what is the agenda for their "pop-up city" in Jan.-Mar. 2025 in Honduras. - What are some of their recent achievents in implants, longevity, and plasmid gene therapy And we'll answer your questions Niklas Anzinger, founder & CEO of Vitalia the health innovation city in Roatan, Honduras. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Americans spend more than anyone on their healthcare. There are only 4 ways to get costs down but breakthroughs are tough. In the show we’ll dive into: - The only way to cut heatlhcare costs are cut prices, cut use, reduce unnecessary services, and replace higher cost services with lower priced ones - We look at each way to cut costs with policy innovation promising to reduce unnecessary services and tech innovation promising to introduce lower cost services - But each move in healthcare is opposed by entrenched interests; who is budging first? And we'll answer your questions Matthew Holt is the President of SMACK Consulting and a healthcare curmudgeon. He is best known as the founder of Health 2.0 and The Health Care Blog (https://thehealthcareblog.com/). Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633 Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Consumers have more options than ever, conglomerates are looking for weakness, what will happen to the drug store? In the show we’ll dive into: Consumers now have more choice than ever before including telehealth prescription companies like Ro and Hims that can cherry-pick the industry Amazon is re-inventing pharmacy-by-mail while CVS and Walgreens are bringing primary care clinics on premises Independent pharmacies are closing at record numbers, turning rural America and inner cities into pharmacy deserts. A volatile mix of labor unrest in the large chain pharmacies plus robotics and AI is creating an uncertain future for a large portion of the country’s registered pharmacists. And we'll answer your questions Harry Travis is the President of Travis Group and a former senior executive at CVS and Aetna. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

New tech is capturing more kinds of data, more continuous data, and data in new care settings that is transforming how we provide care. In the show we’ll dive into: How new technologies are offering a better understanding of disease - more data, more continuous data, and clinical data in more local settings. How better data is offering opportunities to improve care delivery. How rigidities like regulations and payment models are are slowing down more effective care. And we'll answer your questions Tomer Bentzion is the founder and CEO of LiveMetric, the first FDA-cleared wrist-based continuous blood pressure monitoring solution, and a serial entrepreneur. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow him for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633 Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Who stands to eat the most wedges of cheese from the digital health wheel? Payers, Patients, Pharma, software vendors, Providers? In the show we’ll dive into: - The digital health category is maturing as technology stops being shocking and becomes mundane - Competition heats up and differentiation fades; the different actors jocky for position - Who will win the digital health market and be the big cheese? And we'll answer your questions Adam Kaufman is the publisher of BearingOn.Health and an adjunct professor of economics at USC. Follow him at: https://www.linkedin.com/in/adkaufman/. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633 Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Optimal fitness and longevity are an increasingly realistic goal, a lifestyle, and a business opportunity. We discuss. In the show we’ll dive into: Is it possible to achieve optimal fitness as we age? What kind of longevity will be possible in the future? How do we monitor ourselves and maintain a healthy lifestyle? What are some goals for optimal wellness? What are the markets and business opportunities for optimal fitness and longevity? And we'll answer your questions Gil Blander is the Founder and CSO of InsideTracker, an optimal fitness and nutrition company. He is internationally recognized for his research in the basic biology of aging and translating research discoveries into new ways of detecting and preventing age-related conditions. You can follow him at X.com/GBlander1 Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633 Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

In the show we’ll dive into: How AI adds to reading and interpreting genomic information from blood or biopsy Pros & cons of “black box” vs “explainable white box” AI algorithms Where the opportunities are to diagnose and manage disease better What is holding us back from curing inflammatory & autoimmune diseases today? And we'll answer your questions Amrie Grammer, PhD is the Co-Founder and President of Ampel BioSolutions, a precision medicine company that uses RNA analytics and predictive AI to manage disease. Follow her at: https://www.linkedin.com/in/amrie-grammer-phd-1351551b/ Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633 Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ